Scientists have developed a new lung surfactant that is produced synthetically rather than relying on the use of animal tissues. With further development, the formulation could provide a cheaper and ...

Pulmonary surfactant is a complex lipid–protein mixture that coats the alveolar surface, reducing surface tension and preventing alveolar collapse at end-expiration. Its principal lipid component, ...

A recently published preclinical study by researchers at Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, show that vaping may negatively affect ...

Researchers conducted a meta-analysis of 12 randomized controlled trials involving 2428 premature infants, comparing intratracheal budesonide plus pulmonary surfactant with pulmonary surfactant alone.

A team led by University of Minnesota Twin Cities engineering researchers analyzed the fundamental properties and structures of lung surfactant—a naturally occurring substance that helps human and ...

In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...

Pulmonary surfactant proteins are specialised molecules that reduce surface tension in the alveoli and serve as pivotal mediators of lung host defence. Four principal proteins—SP-A, SP-B, SP-C and ...

In late 2019, as the US saw a surge of vaping-related lung injuries, the Centers for Disease Control and Prevention warned against e-cigarette use. Despite the warning, e-cigarette sales have ...

You have millions of air sacs (alveoli) in your lungs. These air sacs move oxygen into your blood. Alveolar walls contain surfactant. This is a substance made of fats, proteins, and other substances.

Surfactants are detergent-like substances in the lungs that dramatically lower the surface tension of the fluid within the air sacs. Particles—including infectious microbes—locate to the distal ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the FDA has extended the review period for the ...

A research team analyzed the fundamental properties and structures of the naturally occurring substances that help human lungs expand and contract, providing insight into how the substances help us ...